Cross-sectional studies reveal a decrease in risk behaviour in injecting drug users, suggesting effective interventions for viral hepatitis elimination.
Key Points
Recent sharing of needles in Oslo declined from 17.8% to 4.2% over 22 years, indicating a significant risk behaviour reduction.
Among 1648 participants, younger individuals showed persistently higher rates of risk behaviour, highlighting a demographic concern.
Analysis involved eight cross-sectional studies to assess injecting drug use and associated risk behaviours over time.
These findings support ongoing public health efforts for viral hepatitis elimination by 2030 in high-risk populations.